The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells (Q35598535)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2015

Language	Label	Description	Also known as
English	The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells	scientific article published on May 2015

Statements

scholarly article

1 reference

Europe PubMed Central

9 August 2017

The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells (English)

1 reference

Europe PubMed Central

9 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Juan Carlos Espín

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Antonio González-Sarrías

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

João Tomé-Carneiro

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Francisco A Tomas-Barberan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Andrea Bellesia

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

1 May 2015

1 reference

Europe PubMed Central

9 August 2017

Food & Function

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1460-1469

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25857357%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Metabolism of capecitabine, an oral fluorouracil prodrug: (19)F NMR studies in animal models and human urine

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Antitumor effect of 5-fluorouracil is enhanced by rosemary extract in both drug sensitive and resistant colon cancer cells.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Polyphenolic compounds in chemoprevention of colon cancer - targets and signaling pathways

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Ellagitannins, ellagic acid and vascular health.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

UV and MS identification of Urolithins and Nasutins, the bioavailable metabolites of ellagitannins and ellagic acid in different mammals.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Strawberry processing does not affect the production and urinary excretion of urolithins, ellagic acid metabolites, in humans.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Modelling the possible bioactivity of ellagitannin-derived metabolites. In silico tools to evaluate their potential xenoestrogenic behavior

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

5-Fluorouracil: mechanisms of action and clinical strategies

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Capecitabine: a review

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Combinations of plant polyphenols & anti-cancer molecules: a novel treatment strategy for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Effect of 5-fluorouracil on cell cycle regulatory proteins in human colon cancer cell line

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Increased cytotoxicity and bystander effect of 5-fluorouracil and 5-deoxy-5-fluorouridine in human colorectal cancer cells transfected with thymidine phosphorylase

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Synergistic inhibitory effects of curcumin and 5-fluorouracil on the growth of the human colon cancer cell line HT-29.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Anti-cancer effects of naturally occurring compounds through modulation of signal transduction and miRNA expression in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Interaction between phenolics and gut microbiota: role in human health.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Anticancer and anti-inflammatory effects of cysteine metabolites of the green tea polyphenol, (-)-epigallocatechin-3-gallate

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Prolonged biologically active colonic tissue levels of curcumin achieved after oral administration--a clinical pilot study including assessment of patient acceptability

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Gastrointestinal microflora and mucins may play a critical role in the development of 5-Fluorouracil-induced gastrointestinal mucositis.

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Multiple molecular mechanisms for multidrug resistance transporters

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Ellagic Acid Metabolism by Human Gut Microbiota: Consistent Observation of Three Urolithin Phenotypes in Intervention Trials, Independent of Food Source, Age, and Health Status

1 reference

https://api.crossref.org/works/10.1039%2FC5FO00120J

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35598535&oldid=1584692865"